| Literature DB >> 35585576 |
Dan Gao1, Fengqi Hu1, Zhao Gao2, Hai Yuan3.
Abstract
BACKGROUND: Secondary hyperparathyroidism (SHPT) remains a common complication in many patients on maintenance hemodialysis. Kidney Disease Improve Global Outcomes (KDIGO) 2017 guidelines suggest that parathyroidectomy (PTX) should be performed in severe SHPT patients with chronic kidney disease stage 3a-stage 5D. In the present study, we observed the efficacy of ultrasonic scalpel for PTX in SHPT patients on maintenance hemodialysis.Entities:
Keywords: Chronic kidney disease; Haemodialysis; Parathyroidectomy; Secondary hyperparathyroidism; Ultrasonic scalpel
Mesh:
Substances:
Year: 2022 PMID: 35585576 PMCID: PMC9118740 DOI: 10.1186/s12893-022-01634-8
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.030
Fig. 1Ultrasonic scalpel is used in PTX. A and B Ultrasonic scalpel device, C Ultrasonic scalpel was used in operation
Fig. 2Parathyroid glands are analyzed by pathological examination. A Parathyroid glands were collected during operation. B Representative H&E staining of parathyroid glands. Original magnification × 100. C Representative H&E staining of parathyroid glands. Original magnification × 200
Demographic and clinic characteristics of patients before PTX
| Electrocautery (34) | Ultrasonic scalpel (40) | P-value | |
|---|---|---|---|
| Age, mean (SD), years | 48.68 ± 11.15 | 50.92 ± 16.17 | 0.645 |
| Months on dialysis, mean (SD) | 98.79 ± 38.99 | 85.62 ± 26.98 | 0.373 |
| Female/male, n (%) | 16 (47.1%) | 21 (52.5%) | 0.816 |
| Body weight (kg) | 66.00 ± 10.23 | 69.09 ± 10.94 | 0.498 |
| Diabetes mellitus, n (%) | 6 (17.6%) | 9 (22.5%) | 0.775 |
| Hypertension, n (%) | 25 (73.5%) | 32 (80.0%) | 0.585 |
| Hepatitis virus, n (%) | 4 (16.7%) | 6 (15.0%) | 0.745 |
| Serum potassium (mmol/L) | 4.24 ± 0.32 | 4.36 ± 0.42 | 0.675 |
| Serum calcium (mmol/L) | 2.48 ± 0.29 | 2.33 ± 0.19 | 0.105 |
| Alkaline phosphate (U/L) | 251.00 (128.00, 526.00) | 402.00 (146.50, 792.50) | 0.377 |
| Triglyceride (mmol/L) | 2.50 ± 0.32 | 2.13 ± 0.56 | 0.317 |
| Total cholesterol (mmol/L) | 4.19 ± 0.83 | 3.87 ± 1.15 | 0.228 |
| Albumin (g/L) | 42.35 ± 5.21 | 39.26 ± 4.00 | 0.082 |
| iPTH, pg/mL | 1433.93 ± 812.04 | 1366.00 ± 747.26 | 0.886 |
| Serum phosphorus (mmol/L) | 2.33 ± 0.66 | 2.48 ± 0.68 | 0.464 |
| Serum magnesium (mmol/L) | 0.98 ± 0.12 | 0.99 ± 0.14 | 0.844 |
Demographic and clinic characteristics of patients after PTX
| Electrocautery (34) | Ultrasonic scalpel (40) | P-value | |
|---|---|---|---|
| Serum phosphorus (mmol/L) | 1.80 ± 0.46 | 1.84 ± 0.38 | 0.759 |
| Serum calcium (mmol/L) | 2.37 ± 0.20 | 2.24 ± 0.22 | 0.096 |
| Serum magnesium (mmol/L) | 0.95 ± 0.09 | 0.93 ± 0.10 | 0.588 |
| Alkaline phosphate (mmol/L) | 517.50 (168.42, 897.54) | 585.70 (148.75, 924.23) | 0.564 |
| iPTH (pg/mL) | 82.55 (29.35, 172.88) | 58.00 (28.25, 182.60) | 0.873 |
Comparison between patients operated with electrocautery and ultrasonic scalpel
| Electrocautery (34) | Ultrasonic scalpel (40) | P-value | |
|---|---|---|---|
| Operating time (min) | 123.00 ± 25.16 | 94.00 ± 16.84 | 0.030 |
| Drainage amount (mL) | 145.58 ± 46.83 | 119.31 ± 51.77 | 0.020 |
| Recurrent laryngeal nerve injury | 1 (2.9%) | 0 (0%) | 0.460 |
| Postoperative infection | 1 (2.9%) | 0 (0%) | 0.460 |
| Number of days with drain | 5.80 ± 2.14 | 4.40 ± 1.62 | 0.042 |
| Postoperative hospital stay (days) | 10.70 ± 4.21 | 8.60 ± 3.65 | 0.030 |